Celldex Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-60.9M | $-62.2M | $1.2M | $9.0M |
| FY2022 | $-103.7M | $-105.6M | $1.8M | $15.6M |
| FY2023 | $-107.3M | $-109.1M | $1.8M | $23.9M |
| FY2024 | $-157.8M | $-159.7M | $1.9M | $34.2M |
| FY2025 | $-210.9M | $-213.7M | $2.7M | $36.2M |